Article
p53 Mutation status predicts pathological response to chemoradiotherapy in locally advanced esophageal cancer.
Annals of surgical oncology - 1 Mar 2010
Makino Tomoki, Yamasaki Makoto, Miyata Hiroshi, Yoshioka Setsuko, Takiguchi Shuji, Fujiwara Yoshiyuki, Nakajima Kiyokazu, Nishida Toshirou, Mori Masaki, Doki Yuichiro
Abstract excerpt
BACKGROUND AND OBJECTIVES: The p53 gene promotes cell-cycle arrest and apoptosis upon DNA damage and is associated with chemo- and radiosensitivity of cancer cells. However, its clinical significance has not been confirmed, especially in squamous cell carcinoma of the esophagus (ESCC). We investigated the correlation between p53 disorders (gene mutation and protein accumulation) and the effects of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
